MSN Slams Novartis’ Latest Bid to Stall Launch of Entresto Copy

MSN Laboratories Pvt. Ltd. accused Novartis AG of trying to to strong-arm a Delaware judge into ruling on its bid to block MSN’s copy of the heart-disease drug Entresto before a July 15 pediatric exclusivity deadline.

Novartis’ June 9 motion for injunctive relief “essentially re-packages its post-trial brief” and relies on “voluminous” new materials while demanding a rushed response, according to a letter to Judge Richard G. Andrews MSN filed Tuesday in the US District Court for the District of Delaware. MSN said Novartis submitted two declarations totaling “almost two hundred pages” but “has the gall” to propose only six ...